|
|
3-Bromo-5-[N-phenyl-N-[2-[2-(1,2,3,4-tetrahydroisoquinolin-2-ylcarbonyloxy)ethylcarbamoyl]ethyl]carbamoyl]-1-propylpyridinium nitrate |
131311-25-6 |
C30H34BrN4O4.NO3 |
|
|
2-[1-(4-Chlorobenzyl)-1H-indol-3-yl]-2-oxo-N-(4-pyridyl)acetamide |
204205-90-3 |
C22H16ClN3O2 |
|
|
N-(2-Isopropoxybenzyl)-1,6-naphthyridine-2-carboxamide |
|
C19H19N3O2 |
|
|
(E)-2,2′-(1,2-Ethenediyl)bis[5-[4,6-bis[3-[bis(3-amino-3-oxopropyl)aminosulfonyl]phenylamino]-1,3,5-triazin-2-ylamino]dibenzenesulfonic acid disodium salt |
197365-86-9; 197366-30-6 (free acid); 200867-42-1 |
C68H78N24O22S6.2Na |
|
|
3,4-Dihydro-1-methyl-6-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)-2(1H)-quinolinone; 6-(5-Methyl-3-oxo-2,3,4,5-tetrahydropyridazin-6-yl)-1-methyl-2-oxo-1,2,3,4-tetrahydroquinoline |
070386-06-0 |
C15H17N3O2 |
|
|
5-Acetamido-2-O-[2,2-bis(docosyloxymethyl)propyl]-3,5-dideoxy-4,7,8,9-tetra-O-sulfo-D-glycero-D-galacto-2-nonulopyranosuronic acid pentasodium salt; N-Acetyl-2-O-[3-(docosyloxy)-2-(docosyloxymethyl)-2-methylpropyl]-alpha-neuraminic acid 4,7,8,9-tetrakis( |
199601-01-9 |
C60H112NO23S4.5Na |
|
|
(±)-1-(3,4-Dimethoxyphenyl)-2-(4-diphenylmethyl-1-piperazinyl)ethanol dihydrochloride; (±)-alpha-(3,4-Dimethoxyphenyl)-4-(diphenylmethyl)-1-piperazineethanol dihydrochloride |
128229-52-7 (free base); 093035-32-6 (free base, n |
C27H32N2O3.2ClH |
|
|
3-Des(hexopyranosyl)-9-deoxo-9(S)-hydroxy-3-O-[2-(3-pyridyl)acetyl]erythromycin A 6-O,9-O:11-O,12-O-bis(cyclic carbonate) |
205320-30-5 |
C38H56N2O13 |
|
|
(?)-N’-Cyano-N-4-pyridinyl-N”-(1,2,2-trimethylpropyl)guanidine monohydrate |
085371-64-8; 060560-33-0 (anhydrous) |
C13H19N5.H2O |
|
|
1-(4-Fluorophenyl)-4-[4-(5-fluoro-2-pyrimidinyl)-1-piperazinyl]butan-1-ol hydrochloride |
099931-60-9 |
C18H22F2N4O.ClH |
